Apolipoprotein E polymorphisms and severity of cerebral palsy: A cross-sectional study in 255 children in Norway

Developmental Medicine and Child Neurology

Volumn 55, Issue 4, 2013, Pages 372-377

  Lien, Espen ^a,b   Andersen, Guro L ^c   Bao, Yongde ^d   Gordish Dressman, Heather ^e   Skranes, Jon S ^a   Vik, Torstein ^a,b   Blackman, James A ^d,f  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c VESTFOLD HOSPITAL TRUST   (Norway)

^d UNIVERSITY OF VIRGINIA   (United States)

^e CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^f Cerebral Palsy International Research Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

ADOLESCENT; ALLELE; ARTICLE; CEREBRAL PALSY; CHILD; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; EPILEPSY; FEMALE; GENOTYPE; GROSS MOTOR FUNCTION CLASSIFICATION SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR PERFORMANCE; NERVE CELL DIFFERENTIATION; NORWAY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN POLYMORPHISM; SCHOOL CHILD; STOMACH TUBE;

ADOLESCENT; APOLIPOPROTEIN E4; BRAIN; CEREBRAL PALSY; CHILD; CROSS-SECTIONAL STUDIES; ENTERAL NUTRITION; EPILEPSY; FEMALE; GASTROSTOMY; GENOTYPE; HUMANS; INCIDENCE; MALE; MOTOR SKILLS; MOVEMENT DISORDERS; NORWAY; ODDS RATIO; POLYMORPHISM, GENETIC; PSYCHOMOTOR PERFORMANCE; SEVERITY OF ILLNESS INDEX;

EID: 84875053334     PISSN: 00121622     EISSN: 14698749     Source Type: Journal    
DOI: 10.1111/dmcn.12086     Document Type: Article

References (28)

1. Bax M, Goldstein M, Rosenbaum P, et al. Proposed definition and classification of cerebral palsy, April 2005. Dev Med Child Neurol 2005; 47: 571-6.
2. Stoknes M, Andersen GL, Elkamil AI, et al. The effects of multiple pre- and perinatal risk factors on the occurrence of cerebral palsy. A Norwegian register based study. Eur J Paediatr Neurol 2012; 16: 56-63.
3. O'Callaghan ME, MacLennan AH, Haan EA, Dekker G. The genomic basis of cerebral palsy: a HuGE systematic literature review. Hum Genet 2009; 126: 149-72.
4. Hauser PS, Narayanaswami V, Ryan RO. Apolipoprotein E: from lipid transport to neurobiology. Prog Lipid Res 2011; 50: 62-74.
5. Jordan BD. Genetic influences on outcome following traumatic brain injury. Neurochem Res 2007; 32: 905-15.
6. Kuroda MM, Weck ME, Sarwark JF, Hamidullah A, Wainwright MS. Association of apolipoprotein E genotype and cerebral palsy in children. Pediatrics 2007; 119: 306-13.
7. Braga LW, Borigato EV, Speck-Martins CE, et al. Apolipoprotein E genotype and cerebral palsy. Dev Med Child Neurol 2010; 52: 666-71.
8. McMichael GL, Gibson CS, Goldwater PN, et al. Association between Apolipoprotein E genotype and cerebral palsy is not confirmed in a Caucasian population. Hum Genet 2008; 124: 411-6.
9. Blackman JA, Gurka MJ, Bao Y, Dragulev BP, Chen WM, Romness MJ. Apolipoprotein E and functional motor severity in cerebral palsy. J Pediatr Rehabil Med 2009; 2: 67-74.
10. Meirelles Kalil Pessoa De B, Rodrigues CJ, De Barros TE, Bevilacqua RG. Presence of apolipoprotein E epsilon4 allele in cerebral palsy. J Pediatr Orthop 2000; 20: 786-9.
11. Corbo RM, Scacchi R. Apolipoprotein E (APOE) allele distribution in the world. Is APOE *4 a 'thrifty' allele?. Ann Hum Genet 1999; 63: 301-10.
12. Oria RB, Patrick PD, Blackman JA, Lima AA, Guerrant RL. Role of apolipoprotein E4 in protecting children against early childhood diarrhea outcomes and implications for later development. Med Hypotheses 2007; 68: 1099-107.
13. Surveillance of Cerebral Palsy in Europe. Surveillance of cerebral palsy in Europe: a collaboration of cerebral palsy surveys and registers. Surveillance of Cerebral Palsy in Europe (SCPE). Dev Med Child Neurol 2000; 42: 816-24.
14. Palisano R, Rosenbaum P, Walter S, Russell D, Wood E, Galuppi B. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol 1997; 39: 214-23.
15. Andersen GL, Irgens LM, Haagaas I, Skranes JS, Meberg AE, Vik T. Cerebral palsy in Norway: prevalence, subtypes and severity. Eur J Paediatr Neurol 2008; 12: 4-13.
16. Beckung E, Hagberg G. Neuroimpairments, activity limitations, and participation restrictions in children with cerebral palsy. Dev Med Child Neurol 2002; 44: 309-16.
17. Kumar T, Liestol K, Maehlen J, et al. Allele frequencies of apolipoprotein E gene polymorphisms in the protein coding region and promoter region (-491A/T) in a healthy Norwegian population. Hum Biol 2002; 74: 137-42.
18. Zhou W, Xu D, Peng X, Zhang Q, Jia J, Crutcher KA. Meta-analysis of APOE4 allele and outcome after traumatic brain injury. J Neurotrauma 2008; 25: 279-90.
19. Teasdale GM, Murray GD, Nicoll JA. The association between APOE epsilon4, age and outcome after head injury: a prospective cohort study. Brain 2005; 128: 2556-61.
20. Brichtova E, Kozak L. Apolipoprotein E genotype and traumatic brain injury in children - association with neurological outcome. Childs Nerv Syst 2008; 24: 349-56.
21. Dumanis SB, Tesoriero JA, Babus LW, et al. ApoE4 decreases spine density and dendritic complexity in cortical neurons in vivo. J Neurosci 2009; 29: 15317-22.
22. Guo L, LaDu MJ, Van Eldik LJ. A dual role for apolipoprotein e in neuroinflammation: anti- and pro-inflammatory activity. J Mol Neurosci 2004; 23: 205-12.
23. Kim J, Basak JM, Holtzman DM. The role of apolipoprotein E in Alzheimer's disease. Neuron 2009; 63: 287-303.
24. Kauffman MA, Consalvo D, Moron DG, Lereis VP, Kochen S. APOE epsilon4 genotype and the age at onset of temporal lobe epilepsy: a case-control study and meta-analysis. Epilepsy Res 2010; 90: 234-9.
25. Verghese PB, Castellano JM, Holtzman DM. Apolipoprotein E in Alzheimer's disease and other neurological disorders. Lancet Neurol 2011; 10: 241-52.
26. Briellmann RS, Torn-Broers Y, Busuttil BE, et al. APOE epsilon4 genotype is associated with an earlier onset of chronic temporal lobe epilepsy. Neurology 2000; 55: 435-7.
27. Diaz-Arrastia R, Gong Y, Fair S, et al. Increased risk of late posttraumatic seizures associated with inheritance of APOE epsilon4 allele. Arch Neurol 2003; 60: 818-22.
28. Aboud O, Mrak RE, Boop F, Griffin ST. Apolipoprotein epsilon3 alleles are associated with indicators of neuronal resilience. BMC Med 2012; 10: 35.